1993
DOI: 10.1097/00000542-199307000-00011
|View full text |Cite
|
Sign up to set email alerts
|

Hemodilution with Oxyhemoglobin Mechanism of Oxygen Delivery and Its Superaugmentation with a Nitric Oxide Donor (Sodium Nitroprusside)

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

1
9
0

Year Published

1994
1994
2003
2003

Publication Types

Select...
7

Relationship

0
7

Authors

Journals

citations
Cited by 34 publications
(10 citation statements)
references
References 0 publications
1
9
0
Order By: Relevance
“…In addition, new evidences against a major role for the decreased blood viscosity on the vasodilatory state associated to anemia, has arised from recent studies demonstrating that haemodilution with oxyhemoglobin does not produce the hyperdynamic circulation despite a marked reduction in blood viscosity (Anand and Chandrashekar 1993). This finding gives support to the hypothesis that low levels of hemoglobin in acute or chronic anemia results in reduced inhibition of basal NO activity leading to generalized vasodilation (Rooney et al 1993), which would be in keeping with the results of the current study. In these circumstances, the increased NO may act as a direct vasodilator activating soluble guanylate cyclase, or indirecty, by inhibiting endothelial production of the potent vasoconstrictors endothelin-1 and PGDF, as recently proposed (Kourembanas et al 1993).…”
Section: Discussionsupporting
confidence: 92%
“…In addition, new evidences against a major role for the decreased blood viscosity on the vasodilatory state associated to anemia, has arised from recent studies demonstrating that haemodilution with oxyhemoglobin does not produce the hyperdynamic circulation despite a marked reduction in blood viscosity (Anand and Chandrashekar 1993). This finding gives support to the hypothesis that low levels of hemoglobin in acute or chronic anemia results in reduced inhibition of basal NO activity leading to generalized vasodilation (Rooney et al 1993), which would be in keeping with the results of the current study. In these circumstances, the increased NO may act as a direct vasodilator activating soluble guanylate cyclase, or indirecty, by inhibiting endothelial production of the potent vasoconstrictors endothelin-1 and PGDF, as recently proposed (Kourembanas et al 1993).…”
Section: Discussionsupporting
confidence: 92%
“…On the other hand, no improvement in tissue O 2 delivery could be demonstrated in a swine resuscitation model with α,α-DBBF-cross-linked Hb ,,,,,, …”
Section: Traumamentioning
confidence: 95%
“…4-fold higher tissue O 2 extraction ratio that is seen with PFCs under normal conditions. In addition, when normovolemic hemodilution is performed, there is normally a substantial increase in cardiac output (the volume of blood ejected from the heart in a given period of time) as a result of increased fluidity of the diluted blood. ,, This increase in cardiac output is preserved when PFC emulsions are administered, which further enhances their O 2 delivery capacity, ,, while Hb products classically display an unchanged or reduced cardiac output that can negate or even outweigh the benefit of increased fluidity. , Further unfounded conclusions have sometimes been drawn on the basis of inadequate protocol design and even on the implicit expectation that the O 2 carrier should still have been active when it was no longer present in the circulation (see, for example, ref and the discussion that followed. , ).…”
Section: Oxygen Delivery To Tissuesmentioning
confidence: 99%
“…3,4 This side effect is now recognized to be caused by the fact that small Hb molecules extravasuate through the vascular endothelium and deplete the nitric oxide (NO), namely, the endothelial-derived relaxing factor, thus inducing the vasoconstriction. [5][6][7][8][9] It has been also shown that these pressor effects elicited by Hb are accompanied by a decrease in the heart rate (HR). 9,10 Although the precise mechanism of this bradycardia is still a source of controversy, the unfavorable hemodynamic alterations may limit the use of the Hb solutions as blood replacement compositions.…”
Section: Introductionmentioning
confidence: 99%